Asker Healthcare Group AB/ADR (ASKRY)

Asker Healthcare Group AB is a Swedish healthcare company that sits at the middle of the care supply chain—not manufacturing the products but distributing and supplying them to care facilities, hospitals, and home care providers across Northern and Central Europe. The business centers on dependable, everyday medical consumables: disposable gloves and protective equipment, wound care materials, urological supplies, diabetes management products, eye surgery equipment, and mobility aids for elderly patients or those recovering from injury.

Based in Danderyd, Sweden, the company operates across a footprint spanning Scandinavia, the Baltics, the Benelux region, and Central Europe. It distributes under its own brands—Evercare for disposables, Selefa for specialized categories, and Embra for certain product lines—alongside products from established manufacturers. This gives Asker a dual role: as a trusted distributor and as a branded supplier that healthcare systems turn to for commodities they order regularly.

The healthcare supply business is fundamentally about reliability and geography—the provider needs the product delivered accurately and on time, every time.

Revenue flows from volume: thousands of care homes, hospitals, and nursing services across multiple countries restocking supplies weekly. The economics are relatively stable given their role as an essential supplier to an aging and growing population across Europe. Asker’s scale—operating in dozens of countries with a workforce numbering in the thousands—is a moat; a fragmented provider in one country can rarely compete with a multinational distributor that can consolidate purchasing, manage logistics, and maintain consistent quality across a continent.

The company was brought public on Nasdaq Stockholm in late March 2025, having been previously held by investment firms and then recapitalized for the listing. Its American Depositary Receipt ticker, ASKRY, reflects the availability of the stock to U.S. investors, though the primary listing remains in Stockholm.